Advisory Council on Blood Stem Cell Transplantation; Request for Nominations for Voting Members, 11491-11492 [2011-4627]

Download as PDF 11491 Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Proposed Project: Retention Survey of NHSC Clinicians and Alumni/NHSC Site Administrators—(OMB No. 0915– NEW) Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request a copy of the clearance requests submitted to OMB for review, e-mail paperwork@hrsa.gov or call the HRSA Reports Clearance Office on (301) 443– 1129. The National Health Service Corps (NHSC) Loan Repayment and Scholarship Programs were established to assure an adequate supply of trained primary care health care professionals to provide services in the neediest Health Professional Shortage Areas (HPSAs) of the United States. Under these programs, the Department of Health and Human Services agrees to repay the educational loans of, or provide scholarships to, primary care health professionals. In return, the Number of respondents Instrument Survey Survey Survey Survey Survey Survey of of of of of of Responses per respondent professionals agree to serve for a specified period of time in a federally designated HPSA approved by the Secretary. The last survey conducted to analyze retention of NHSC clinicians is more than 10 years old. There is a need to distribute a survey to reevaluate the personal/professional development of NHSC clinicians in an effort to retain the clinicians in service providing care for individuals residing in underserved areas. The survey will ask current and former NHSC clinicians questions regarding professional satisfaction, expectations of being in the NHSC, and about their experiences at NHSC sites. The survey will also ask NHSC site administrators questions about the sites and about the attributes of the current and former NHSC clinicians at sites. The annual estimate of burden is as follows: Total responses Hours per response Total burden hours Site Administrators .......................................... NHSC Clinicians in Service (LRP) .................. NHSC Clinicians in Service (Scholars) ........... NHSC Recent Alumni (LRP) ........................... NHSC Recent Alumni (Scholars) .................... Remote NHSC Alumni .................................... 500 2,740 536 2,393 435 860 1 1 1 1 1 1 500 2,740 536 2,393 435 860 .125 .11 .14 .23 .10 .15 62.50 301.40 75.04 550.39 43.50 129 Total .......................................................................... 7,464 ........................ 7,464 .......................... 1161.83 Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by fax to 202–395–6974. Please direct all correspondence to the ‘‘attention of the desk officer for HRSA.’’ Dated: February 24, 2011. Reva Harris, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2011–4623 Filed 3–1–11; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES emcdonald on DSK2BSOYB1PROD with NOTICES Health Resources and Services Administration Advisory Council on Blood Stem Cell Transplantation; Request for Nominations for Voting Members Health Resources and Services Administration (HRSA), HHS. ACTION: Notice. AGENCY: The Health Resources and Services Administration (HRSA) is SUMMARY: VerDate Mar<15>2010 16:34 Mar 01, 2011 Jkt 223001 requesting nominations to fill expected vacancies on the Advisory Council on Blood Stem Cell Transplantation. The Advisory Council on Blood Stem Cell Transplantation was established pursuant to Public Law 109–129 as amended by Public Law 111–264; 42 U.S.C. 274k; Section 379 of the Public Health Service Act. In accordance with Public Law 92–463, the Council was chartered on December 19, 2006. DATES: The agency must receive nominations on or before April 1, 2011. ADDRESSES: Nominations should be submitted to the Executive Secretary, Advisory Council on Blood Stem Cell Transplantation, Healthcare Systems Bureau, HRSA, Parklawn Building, Room 12C–06, 5600 Fishers Lane, Rockville, Maryland 20857. Federal Express, Airborne, UPS, or mail delivery should be addressed to Executive Secretary, Advisory Council on Blood Stem Cell Transplantation, Healthcare Systems Bureau, HRSA, at the above address. Nominations submitted electronically should be e-mailed to ptongele@hrsa.gov. FOR FURTHER INFORMATION CONTACT: Patricia A. Stroup, M.B.A., M.P.A., Executive Secretary, Advisory Council on Blood Stem Cell Transplantation, at PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 (301) 443–1127 or e-mail pstroup@hrsa.gov or Robert Baitty, Director, Blood Stem Cell Transplantation Program, Division of Transplantation, at (301) 443–2612 or e-mail rbaitty@hrsa.gov. SUPPLEMENTARY INFORMATION: The Council was established to implement a statutory requirement of the Stem Cell Therapeutic and Research Act of 2005 (Pub. L. 109–129). The Council is governed by the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. The Advisory Council advises the Secretary and the Administrator, HRSA, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory Program. The Council shall, as requested by the Secretary, discuss and make recommendations regarding the C.W. Bill Young Cell Transplantation Program (Program). It shall provide a consolidated, comprehensive source of expert, unbiased analysis and recommendations to the Secretary on the latest advances in the science of blood stem cell transplantation. The E:\FR\FM\02MRN1.SGM 02MRN1 emcdonald on DSK2BSOYB1PROD with NOTICES 11492 Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices Council shall advise, assist, consult and make recommendations, at the request of the Secretary, on broad Program policy in areas such as the necessary size and composition of the adult donor pool available through the Program and the composition of the National Cord Blood Inventory, requirements regarding informed consent for cord blood donation, accreditation requirements for cord blood banks, the scientific factors that define a cord blood unit as high quality, public and professional education to encourage the ethical recruitment of genetically diverse donors and ethical donation practices, criteria for selecting the appropriate blood stem source for transplantation, Program priorities, research priorities, and the scope and design of the Stem Cell Therapeutic Outcomes Database. It also shall, at the request of the Secretary, review and advise on issues relating more broadly to the field of blood stem cell transplantation, such as regulatory policy including compatibility of international regulations, and actions that may be taken by the State and Federal Governments and public and private insurers to increase donation and access to transplantation. The Advisory Council also shall make recommendations regarding research on emerging therapies using cells from bone marrow and cord blood. The Council consists of up to 25 members, including the Chair. Members of the Advisory Council shall be chosen to ensure objectivity and balance, and reduce the potential for conflicts of interest. The Secretary shall establish bylaws and procedures to prohibit any member of the Advisory Council who has an employment, governance, or financial affiliation with a donor center, recruitment organization, transplant center, or cord blood bank from participating in any decision that materially affects the center, recruitment organization, transplant center, or cord blood bank; and to limit the number of members of the Advisory Council with any such affiliation. The members and chair shall be selected by the Secretary from outstanding authorities and representatives of marrow donor centers and marrow transplant centers; representatives of cord blood banks and participating birthing hospitals; recipients of a bone marrow transplant; recipients of a cord blood transplant; persons who require such transplants; family members of such a recipient or family members of a patient who has requested the assistance of the Program in searching for an unrelated donor of bone marrow or cord blood; persons VerDate Mar<15>2010 16:34 Mar 01, 2011 Jkt 223001 with expertise in bone marrow and cord blood transplantation; persons with expertise in typing, matching, and transplant outcome data analysis; persons with expertise in the social sciences; basic scientists with expertise in the biology of adult stem cells; ethicists, hematology and transfusion medicine researchers with expertise in adult blood stem cells; persons with expertise in cord blood processing; and members of the general public. In addition, representatives from the Division of Transplantation of the Health Resources and Services Administration, the Department of Defense Marrow Recruitment and Research Program operated by the Department of the Navy, the Food and Drug Administration, the National Institutes of Health, the Centers for Medicare and Medicaid Services, and the Centers for Disease Control and Prevention serve as non-voting ex officio members. Specifically, HRSA is requesting nominations for voting members of the Advisory Council on Blood Stem Cell Transplantation in these categories: marrow donor centers and transplant center representatives; cord blood banks and participating hospitals representatives; recipients of cord blood transplant; family members of bone marrow transplant and cord blood transplant recipients or family members of a patient who has requested assistance by the Program in searching for an unrelated donor; persons with expertise in bone marrow or cord blood transplantation; persons with expertise in typing, matching, and transplant outcome data analysis; persons with expertise in social sciences; basic scientists with expertise in the biology of adult stem cells; researchers in hematology and transfusion medicine with expertise in adult blood stem cells; persons with expertise in cord blood processing; and members of the general public. Nominees will be invited to serve a 2- to 6-year term beginning after January 1, 2012. HHS will consider nominations of all qualified individuals to ensure that the Advisory Council includes the areas of subject matter expertise noted above. Individuals may nominate themselves or other individuals, and professional associations and organizations may nominate one or more qualified persons for membership on the Advisory Council. Nominations shall state that the nominee is willing to serve as a member of the Council. Potential candidates will be asked to provide detailed information concerning financial interests, consultancies, research grants, and/or contracts that PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 might be affected by recommendations of the Council to permit evaluation of possible sources of conflicts of interest. In addition, nominees will be asked to provide detailed information concerning any employment, governance, or financial affiliation with any donor centers, recruitment organizations, transplant centers, and/or cord blood banks. A nomination package should be sent in as hard copy, e-mail communication, or on compact disc. A nomination package should include the following information for each nominee: (1) A letter of nomination stating the name, affiliation, and contact information for the nominee, the basis for the nomination (i.e., what specific attributes recommend him/her for service in this capacity), and the nominee’s field(s) of expertise; (2) a biographical sketch of the nominee and a copy of his/her curriculum vitae; and (3) the name, return address, e-mail address, and daytime telephone number at which the nominator can be contacted. The Department strives to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Every effort is made to ensure that the views of women, all ethnic and racial groups, and people with disabilities are represented on HHS Federal advisory committees and, therefore, the Department encourages nominations of qualified candidates from these groups. The Department also encourages geographic diversity in the composition of the committee. Appointment to this Council shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. Dated: February 24, 2011. Reva Harris, Acting Director, Division of Policy and Information Coordination. [FR Doc. 2011–4627 Filed 3–1–11; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Notice for Request for Nominations Health Resources and Services Administration, HHS. ACTION: Request for Nominations. AGENCY: The Health Resources and Services Administration (HRSA) is SUMMARY: E:\FR\FM\02MRN1.SGM 02MRN1

Agencies

[Federal Register Volume 76, Number 41 (Wednesday, March 2, 2011)]
[Notices]
[Pages 11491-11492]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4627]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation; Request for 
Nominations for Voting Members

AGENCY: Health Resources and Services Administration (HRSA), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
requesting nominations to fill expected vacancies on the Advisory 
Council on Blood Stem Cell Transplantation.
    The Advisory Council on Blood Stem Cell Transplantation was 
established pursuant to Public Law 109-129 as amended by Public Law 
111-264; 42 U.S.C. 274k; Section 379 of the Public Health Service Act. 
In accordance with Public Law 92-463, the Council was chartered on 
December 19, 2006.

DATES: The agency must receive nominations on or before April 1, 2011.

ADDRESSES: Nominations should be submitted to the Executive Secretary, 
Advisory Council on Blood Stem Cell Transplantation, Healthcare Systems 
Bureau, HRSA, Parklawn Building, Room 12C-06, 5600 Fishers Lane, 
Rockville, Maryland 20857. Federal Express, Airborne, UPS, or mail 
delivery should be addressed to Executive Secretary, Advisory Council 
on Blood Stem Cell Transplantation, Healthcare Systems Bureau, HRSA, at 
the above address. Nominations submitted electronically should be e-
mailed to ptongele@hrsa.gov.

FOR FURTHER INFORMATION CONTACT: Patricia A. Stroup, M.B.A., M.P.A., 
Executive Secretary, Advisory Council on Blood Stem Cell 
Transplantation, at (301) 443-1127 or e-mail pstroup@hrsa.gov or Robert 
Baitty, Director, Blood Stem Cell Transplantation Program, Division of 
Transplantation, at (301) 443-2612 or e-mail rbaitty@hrsa.gov.

SUPPLEMENTARY INFORMATION: The Council was established to implement a 
statutory requirement of the Stem Cell Therapeutic and Research Act of 
2005 (Pub. L. 109-129). The Council is governed by the Federal Advisory 
Committee Act, as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of advisory committees.
    The Advisory Council advises the Secretary and the Administrator, 
HRSA, on matters related to the activities of the C.W. Bill Young Cell 
Transplantation Program and the National Cord Blood Inventory Program.
    The Council shall, as requested by the Secretary, discuss and make 
recommendations regarding the C.W. Bill Young Cell Transplantation 
Program (Program). It shall provide a consolidated, comprehensive 
source of expert, unbiased analysis and recommendations to the 
Secretary on the latest advances in the science of blood stem cell 
transplantation. The

[[Page 11492]]

Council shall advise, assist, consult and make recommendations, at the 
request of the Secretary, on broad Program policy in areas such as the 
necessary size and composition of the adult donor pool available 
through the Program and the composition of the National Cord Blood 
Inventory, requirements regarding informed consent for cord blood 
donation, accreditation requirements for cord blood banks, the 
scientific factors that define a cord blood unit as high quality, 
public and professional education to encourage the ethical recruitment 
of genetically diverse donors and ethical donation practices, criteria 
for selecting the appropriate blood stem source for transplantation, 
Program priorities, research priorities, and the scope and design of 
the Stem Cell Therapeutic Outcomes Database. It also shall, at the 
request of the Secretary, review and advise on issues relating more 
broadly to the field of blood stem cell transplantation, such as 
regulatory policy including compatibility of international regulations, 
and actions that may be taken by the State and Federal Governments and 
public and private insurers to increase donation and access to 
transplantation. The Advisory Council also shall make recommendations 
regarding research on emerging therapies using cells from bone marrow 
and cord blood.
    The Council consists of up to 25 members, including the Chair. 
Members of the Advisory Council shall be chosen to ensure objectivity 
and balance, and reduce the potential for conflicts of interest. The 
Secretary shall establish bylaws and procedures to prohibit any member 
of the Advisory Council who has an employment, governance, or financial 
affiliation with a donor center, recruitment organization, transplant 
center, or cord blood bank from participating in any decision that 
materially affects the center, recruitment organization, transplant 
center, or cord blood bank; and to limit the number of members of the 
Advisory Council with any such affiliation.
    The members and chair shall be selected by the Secretary from 
outstanding authorities and representatives of marrow donor centers and 
marrow transplant centers; representatives of cord blood banks and 
participating birthing hospitals; recipients of a bone marrow 
transplant; recipients of a cord blood transplant; persons who require 
such transplants; family members of such a recipient or family members 
of a patient who has requested the assistance of the Program in 
searching for an unrelated donor of bone marrow or cord blood; persons 
with expertise in bone marrow and cord blood transplantation; persons 
with expertise in typing, matching, and transplant outcome data 
analysis; persons with expertise in the social sciences; basic 
scientists with expertise in the biology of adult stem cells; 
ethicists, hematology and transfusion medicine researchers with 
expertise in adult blood stem cells; persons with expertise in cord 
blood processing; and members of the general public.
    In addition, representatives from the Division of Transplantation 
of the Health Resources and Services Administration, the Department of 
Defense Marrow Recruitment and Research Program operated by the 
Department of the Navy, the Food and Drug Administration, the National 
Institutes of Health, the Centers for Medicare and Medicaid Services, 
and the Centers for Disease Control and Prevention serve as non-voting 
ex officio members.
    Specifically, HRSA is requesting nominations for voting members of 
the Advisory Council on Blood Stem Cell Transplantation in these 
categories: marrow donor centers and transplant center representatives; 
cord blood banks and participating hospitals representatives; 
recipients of cord blood transplant; family members of bone marrow 
transplant and cord blood transplant recipients or family members of a 
patient who has requested assistance by the Program in searching for an 
unrelated donor; persons with expertise in bone marrow or cord blood 
transplantation; persons with expertise in typing, matching, and 
transplant outcome data analysis; persons with expertise in social 
sciences; basic scientists with expertise in the biology of adult stem 
cells; researchers in hematology and transfusion medicine with 
expertise in adult blood stem cells; persons with expertise in cord 
blood processing; and members of the general public. Nominees will be 
invited to serve a 2- to 6-year term beginning after January 1, 2012.
    HHS will consider nominations of all qualified individuals to 
ensure that the Advisory Council includes the areas of subject matter 
expertise noted above. Individuals may nominate themselves or other 
individuals, and professional associations and organizations may 
nominate one or more qualified persons for membership on the Advisory 
Council. Nominations shall state that the nominee is willing to serve 
as a member of the Council. Potential candidates will be asked to 
provide detailed information concerning financial interests, 
consultancies, research grants, and/or contracts that might be affected 
by recommendations of the Council to permit evaluation of possible 
sources of conflicts of interest. In addition, nominees will be asked 
to provide detailed information concerning any employment, governance, 
or financial affiliation with any donor centers, recruitment 
organizations, transplant centers, and/or cord blood banks.
    A nomination package should be sent in as hard copy, e-mail 
communication, or on compact disc. A nomination package should include 
the following information for each nominee: (1) A letter of nomination 
stating the name, affiliation, and contact information for the nominee, 
the basis for the nomination (i.e., what specific attributes recommend 
him/her for service in this capacity), and the nominee's field(s) of 
expertise; (2) a biographical sketch of the nominee and a copy of his/
her curriculum vitae; and (3) the name, return address, e-mail address, 
and daytime telephone number at which the nominator can be contacted.
    The Department strives to ensure that the membership of HHS Federal 
advisory committees is fairly balanced in terms of points of view 
represented and the committee's function. Every effort is made to 
ensure that the views of women, all ethnic and racial groups, and 
people with disabilities are represented on HHS Federal advisory 
committees and, therefore, the Department encourages nominations of 
qualified candidates from these groups. The Department also encourages 
geographic diversity in the composition of the committee. Appointment 
to this Council shall be made without discrimination on the basis of 
age, race, ethnicity, gender, sexual orientation, disability, and 
cultural, religious, or socioeconomic status.

    Dated: February 24, 2011.
Reva Harris,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2011-4627 Filed 3-1-11; 8:45 am]
BILLING CODE 4165-15-P